IPSC-CL

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
210	単心室症	1

210. 単心室症

臨床試験数 : 51 / 薬物数 : 53 - (DrugBank : 22) / 標的遺伝子数 : 32 - 標的パスウェイ数 : 67

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05647213 (ClinicalTrials.gov)	February 3, 2023	30/11/2022	Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease	Safety and Feasibility of Autologous Induced Pluripotent Stem Cells of Cardiac Lineage in Subjects W ...	Univentricular Heart;Congenital Heart Disease;Heart Failure NYHA Class III;Heart Failure NYHA Class ...	Biological: iPSC-CL	HeartWorks, Inc.	NULL	Recruiting	18 Years	40 Years	All	50	Phase 1	United States

First Previous1Next Last